Tg Therapeutics (TGTX) Debt Ratio (2019 - 2025)
Historic Debt Ratio for Tg Therapeutics (TGTX) over the last 7 years, with Q3 2025 value amounting to 0.24.
- Tg Therapeutics' Debt Ratio fell 4255.25% to 0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24, marking a year-over-year decrease of 4255.25%. This contributed to the annual value of 0.42 for FY2024, which is 3928.87% up from last year.
- Per Tg Therapeutics' latest filing, its Debt Ratio stood at 0.24 for Q3 2025, which was down 4255.25% from 0.35 recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Debt Ratio ranged from a high of 0.49 in Q1 2023 and a low of 0.04 during Q3 2021
- Moreover, its 5-year median value for Debt Ratio was 0.3 (2023), whereas its average is 0.28.
- As far as peak fluctuations go, Tg Therapeutics' Debt Ratio plummeted by 8084.95% in 2021, and later soared by 73599.44% in 2022.
- Quarter analysis of 5 years shows Tg Therapeutics' Debt Ratio stood at 0.18 in 2021, then soared by 105.88% to 0.37 in 2022, then decreased by 17.34% to 0.3 in 2023, then soared by 39.29% to 0.42 in 2024, then crashed by 43.43% to 0.24 in 2025.
- Its Debt Ratio stands at 0.24 for Q3 2025, versus 0.35 for Q2 2025 and 0.37 for Q1 2025.